Heron Neutron Medical Corp. (TPE:7799)

Taiwan · Delayed Price · Currency is TWD

357.00

-4.50 (-1.24%)

At close: Aug 6, 2026

-59.15% (1Y)

Market Cap	56.40B -54.1%
Revenue (ttm)	11.69M +482.1%
Net Income	-479.38M
EPS	-3.11
Shares Out	158.00M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	249,181
Open	360.50
Previous Close	361.50
Day's Range	354.00 - 364.50
52-Week Range	300.00 - 932.00
Beta	n/a
Analysts	Strong Buy
Price Target	980.00 (+174.51%)
Earnings Date	Jul 31, 2026

About Heron Neutron Medical

Heron Neutron Medical Corp. develops, manufactures, and sells medical instruments. It offers accelerator-based boron neutron capture therapy solutions, including neutron source target system, accelerator system, target system, beam shaping assembly, treatment control system, treatment planning system, and patient positioning system; and ACSI cyclotron products. The company was founded in 2017 and is based in Zhubei, Taiwan. [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2017

Employees 104

Stock Exchange Taiwan Stock Exchange

Ticker Symbol 7799

Full Company Profile

Financial Performance

Financial Statements

Analyst Summary

According to 4 analysts, the average rating for 7799 stock is "Strong Buy." The 12-month stock price target is $980.00, which is an increase of 174.51% from the latest price.

Price Target

$980.00

(174.51% upside)

Analyst Consensus: Strong Buy

Stock Forecasts